Watch Peter Block, MD, FACC, and Eva M. Lonn, M.D., FACC, discuss results from the HOPE-3 Trial.

Keywords: ACC Annual Scientific Session, Benzimidazoles, Blood Pressure, Cholesterol, LDL, Dyslipidemias, Heart Arrest, Heart Failure, Hydrochlorothiazide, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hypertension, Hypotension, Lipids, Metabolic Syndrome, Myocardial Infarction, Primary Prevention, Risk, Stroke, Tetrazoles

< Back to Listings